6.
Nicol M, Eneh P, Nakalega R, Kaiser T, Kabwigu S, Isingel E
. Depot Medroxyprogesterone Acetate and the Vaginal Microbiome as Modifiers of Tenofovir Diphosphate and Lamivudine Triphosphate Concentrations in the Female Genital Tract of Ugandan Women: Implications for Tenofovir Disoproxil Fumarate/Lamivudine in.... Clin Infect Dis. 2019; 70(8):1717-1724.
PMC: 7146007.
DOI: 10.1093/cid/ciz443.
View
7.
Li W, Godzik A
. Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics. 2006; 22(13):1658-9.
DOI: 10.1093/bioinformatics/btl158.
View
8.
Taylor L, Keeler E, Bushman F, Collman R
. The enigmatic roles of Anelloviridae and Redondoviridae in humans. Curr Opin Virol. 2022; 55:101248.
DOI: 10.1016/j.coviro.2022.101248.
View
9.
Taneva E, Sinclair S, Mesquita P, Weinrick B, Cameron S, Cheshenko N
. Vaginal microbiome modulates topical antiretroviral drug pharmacokinetics. JCI Insight. 2018; 3(13).
PMC: 6124523.
DOI: 10.1172/jci.insight.99545.
View
10.
Shibayama T, Masuda G, Ajisawa A, Takahashi M, Nishizawa T, Tsuda F
. Inverse relationship between the titre of TT virus DNA and the CD4 cell count in patients infected with HIV. AIDS. 2001; 15(5):563-70.
DOI: 10.1097/00002030-200103300-00004.
View
11.
Ghosn J, Taiwo B, Seedat S, Autran B, Katlama C
. HIV. Lancet. 2018; 392(10148):685-697.
DOI: 10.1016/S0140-6736(18)31311-4.
View
12.
Liu C, Packman Z, Abraham A, Serwadda D, Nalugoda F, Aziz M
. The Effect of Antiretroviral Therapy Initiation on the Vaginal Microbiome in HIV-Infected Women. Open Forum Infect Dis. 2019; 6(9):ofz328.
PMC: 6798248.
DOI: 10.1093/ofid/ofz328.
View
13.
Uvin S, Caliendo A
. Cervicovaginal human immunodeficiency virus secretion and plasma viral load in human immunodeficiency virus-seropositive women. Obstet Gynecol. 1997; 90(5):739-43.
DOI: 10.1016/S0029-7844(97)00411-0.
View
14.
Gajer P, Brotman R, Bai G, Sakamoto J, Schutte U, Zhong X
. Temporal dynamics of the human vaginal microbiota. Sci Transl Med. 2012; 4(132):132ra52.
PMC: 3722878.
DOI: 10.1126/scitranslmed.3003605.
View
15.
France M, Alizadeh M, Brown S, Ma B, Ravel J
. Towards a deeper understanding of the vaginal microbiota. Nat Microbiol. 2022; 7(3):367-378.
PMC: 8910585.
DOI: 10.1038/s41564-022-01083-2.
View
16.
Gudnadottir U, Debelius J, Du J, Hugerth L, Danielsson H, Schuppe-Koistinen I
. The vaginal microbiome and the risk of preterm birth: a systematic review and network meta-analysis. Sci Rep. 2022; 12(1):7926.
PMC: 9106729.
DOI: 10.1038/s41598-022-12007-9.
View
17.
Beghini F, McIver L, Blanco-Miguez A, Dubois L, Asnicar F, Maharjan S
. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. Elife. 2021; 10.
PMC: 8096432.
DOI: 10.7554/eLife.65088.
View
18.
Borgdorff H, van der Veer C, van Houdt R, Alberts C, de Vries H, Bruisten S
. The association between ethnicity and vaginal microbiota composition in Amsterdam, the Netherlands. PLoS One. 2017; 12(7):e0181135.
PMC: 5507447.
DOI: 10.1371/journal.pone.0181135.
View
19.
Bull M, Mitchell C, Soria J, Styrchak S, Williams C, Dragavon J
. Genital Shedding of Human Immunodeficiency Virus Type-1 (HIV) When Antiretroviral Therapy Suppresses HIV Replication in the Plasma. J Infect Dis. 2020; 222(5):777-786.
PMC: 7399698.
DOI: 10.1093/infdis/jiaa169.
View
20.
Cheu R, Gustin A, Lee C, Schifanella L, Miller C, Ha A
. Impact of vaginal microbiome communities on HIV antiretroviral-based pre-exposure prophylaxis (PrEP) drug metabolism. PLoS Pathog. 2020; 16(12):e1009024.
PMC: 7714160.
DOI: 10.1371/journal.ppat.1009024.
View